Results 191 to 200 of about 66,290,039 (265)

Biomarkers and arterial stiffness. A sub-analysis of the "Exercise training in heart failure with reduced ejection fraction and permanent atrial fibrillation: A randomized clinical trial". [PDF]

Clinics (Sao Paulo)
Guimarães GV, D' Avila VM, Chizzola PR, Alvarez C, Bocchi EA.   +4 more
europepmc   +1 more source

Maximum Allowable Contrast Dose and Risk of Acute Kidney Injury After Coronary Procedures

Catheterization and Cardiovascular Interventions, EarlyView.
ABSTRACT Background Recent studies have questioned whether iodinated contrast is causally related to acute kidney injury (AKI). AIM We pursed a contemporary analysis to determine the impact of contrast dose on AKI following coronary procedures in an era of lower contrast doses and less nephrotoxic agents.
Harshita Gaba, Elise Mesenbring, Christine Chow, Jennifer A. Rymer, Celina M. Yong, Stephen W. Waldo, Jacob A. Doll   +6 more
wiley   +1 more source

Combined Left Ventricular and Left Atrial Strain Assessment for Long-Term Risk Stratification in Heart Failure With Reduced Ejection Fraction. [PDF]

Echocardiography
Maksimovic A, Neskovic SA, Scepanovic M, Zivanic A, Stankovic I.   +4 more
europepmc   +1 more source

Successful Percutaneous Retrieval of an Embolized MitraClip From the Right Subclavian Artery

Catheterization and Cardiovascular Interventions, EarlyView.
ABSTRACT Single leaflet device attachment (SLDA) after mitral transcatheter valve edge‐to‐edge repair (M‐TEER) has been reported in up to 5% of patients. However, complete embolization of the M‐TEER device is exceedingly rare. Device retrievals in all previously reported cases were completed by vascular surgery cut down at the end. In this case, we are
Seyed Hossein Aalaei‐Andabili, Diljon S. Chahal, Shahab Tour Savadkohi   +2 more
wiley   +1 more source

Glucagon-like peptide-1 receptor agonists for heart failure with reduced ejection fraction: Is it the next step? [PDF]

ESC Heart Fail
Biegus J.
europepmc   +1 more source

Novel Use of Intravascular Lithotripsy for the Mobilization of an Entrapped Coronary Guidewire in a Heavily Calcified LAD/DB Bifurcation Lesion—A Case Report

Catheterization and Cardiovascular Interventions, EarlyView.
ABSTRACT A 64‑year‑old man with a Non–ST‑elevation myocardial infarction (NSTEMI) underwent coronary angiography, which revealed single‑vessel disease with a high‑grade proximal and a severely calcified mid‑LAD lesion just proximal to a diagonal branch (DB). Both the LAD and the DB were wired.
Hansmartin Jetter, Jochen Genzel, Wolfram Voelker   +2 more
wiley   +1 more source

Temporal Trends and Predictors of Mortality in Heart Failure with Reduced Ejection Fraction: The Role of Renal Function and Left Ventricular Improvement. [PDF]

J Clin Med
Lopez-Lopez A, Rivas Vázquez E, Regueiro-Abel M, Álvarez-Suárez CC, Abou Johk-Casas C, Elices-Teja J, Ríos Vázquez R, Santamarina-Pernas G, González-Juanatey C.   +8 more
europepmc   +1 more source

Incidence of Periprocedural Myocardial Injury and Infarction After Intravascular Lithotripsy for Calcified Coronary Artery Stenosis

Catheterization and Cardiovascular Interventions, EarlyView.
ABSTRACT Background Intravascular lithotripsy (IVL) has emerged as an effective technique for modifying heavily calcified coronary plaques, facilitating optimal stent expansion while minimizing procedural complications. However, data on periprocedural myocardial injury (PMI) and infarction (PPMI) following IVL remain scarce.
Gwaenaelle Aellen, Dorian Garin, Yannick Faucherre, Serban Puricel, Mario Togni, Stéphane Cook   +5 more
wiley   +1 more source

Cerebral Ventricular Dimensions in Patients with Heart Failure with Reduced Ejection Fraction (HFrEF): A Cross-Sectional MRI Study. [PDF]

Int J Gen Med
Alan B.
europepmc   +1 more source

Five‐Year Clinical Outcomes of Biodegradable Versus Durable Polymer Drug‐Eluting Stents: A Propensity Score‐Matched Analysis of 4394 Patients

Catheterization and Cardiovascular Interventions, EarlyView.
ABSTRACT Background Biodegradable‐polymer (BP) drug‐eluting stents (DES) were developed to mitigate potential late adverse events related to persistent durable polymers in durable‐polymer (DP) DES; however, contemporary long‐term real‐world comparative data remain limited. Aims We aimed to compare the 5‐year clinical outcomes of contemporary BP‐DES and
Yangyoun Lee, Hong‐Seok Lim, Kyoung‐Woo Seo, Hyoung‐Mo Yang, So‐Yeon Choi, Seung‐Jea Tahk, Myeong‐Ho Yoon   +6 more
wiley   +1 more source